Mabwell, an innovation-focused biopharmaceutical company with an integrated end-to-end pharmaceutical value chain, announced that its wholly owned subsidiary, T-mab, has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP on-site …